Claudio Bordignon

Founder & SAB President at Molecular Medicine

MolMed's Founder and SAB President – Founding Member of the Scientific Council at European Research Council; Professor of Hematology at Vita-Salute University, San Raffaele Hospital, Milan, Italy.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Molecular Medicine

MolMed S.p.A. is a clinical-stage biotech company focused on research, development, manufacturing, and clinical validation of innovative therapies. MolMed's product portfolio includes proprietary anti-tumor therapies in both clinical and preclinical development, both autologous and allogeneic.


Industries

Headquarters

Milan, Italy

Employees

51-200

Links